Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl) methyl)urea hydrochloride and compositions, methods and kits related thereto

• 收藏
• 分享

专利权人:

Inc.;Millendo Therapeutics

发明人:

Hunt III, Stephen Warren,Phillips, Martin Douglas,Matunas, Robert,Chen, Herman,Betancourt, Aimesther,Uzarama, Charles,Thibert, Roch

申请号：

AU2015320358

公开号：

AU2015320358A1

申请日:

2015.09.25

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

A novel solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride (also referred to "ATR-101") suitable for oral dosing, and to compositions, methods and kits relating thereto. ATR-101 has particular utility in the treatment of, for example, aberrant adrenocortical cellular activity, including adrenocortical carcinoma (ACC), congenital adrenal hyperplasia (CAH) and Cushing's syndrome.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/